David A. Flockhart (1952–2015) was a Scottish medical researcher who was a leader in the field of

personalised medicine Personalized medicine, also referred to as precision medicine, is a medical model that separates people into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on thei ...

. He was especially known for his work on factors affecting the use of

tamoxifen Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and treat breast cancer in women and men. It is also being studied for other types of cancer. It has b ...

to treat

breast cancer Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a re ...

such as variability in the level of the CYP2D6 enzyme.

References

1952 births 2015 deaths 20th-century Scottish medical doctors {{physician-stub